Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | MGLL | Q99685 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.33 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.33 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12757491 | 1.00 | SMN1; SMN2 (0.40) | SMN1; SMN2ALDH1A1HPGDADRB1ALOX5 | |
| SCHEMBL23680805 | 0.75 | MAPK1 (0.37) | SMN1; SMN2ALDH1A1HPGDALOX5MAPT | |
| SCHEMBL19725777 | 0.74 | ALDH1A1 (0.42) | SMN1; SMN2ALDH1A1HPGDADRB1ALOX5 | |
| SCHEMBL22753233 | 0.68 | ADRB1 (0.47) | SMN1; SMN2ALDH1A1HPGDADRB1ALOX5 | |
| SCHEMBL9891021 | 0.68 | ALDH1A1 (0.37) | SMN1; SMN2ALDH1A1HPGDADRB1MAPT | |
| SCHEMBL12643066 | 0.68 | ALDH1A1 (0.37) | SMN1; SMN2ALDH1A1HPGDADRB1MAPT | |
| SCHEMBL11995094 | 0.68 | ALDH1A1 (0.37) | SMN1; SMN2ALDH1A1HPGDADRB1MAPT | |
| SCHEMBL19258231 | 0.68 | ALDH1A1 (0.38) | SMN1; SMN2ALDH1A1HPGDADRB1ALOX5 | |
| SCHEMBL16716079 | 0.68 | ALDH1A1 (0.38) | SMN1; SMN2ALDH1A1HPGDADRB1ALOX5 | |
| SCHEMBL17886085 | 0.68 | ALDH1A1 (0.38) | SMN1; SMN2ALDH1A1HPGDADRB1ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9837625-B2 | Organic electroluminescent element | Konica Minolta, Inc. (JP) | 2017-12-05 | — | — | US | disclosed |
| US-9780322-B2 | Organic electroluminescent element | Konica Minolta, Inc. (JP) | 2017-10-03 | — | — | US | disclosed |
| US-20160315273-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, LIGHTING DEVICE, AND DISPLAY DEVICE | Konica Minolta, Inc. (JP) | 2016-10-27 | — | — | US | disclosed |
| US-9437833-B2 | Organic electroluminescence element | Konica Minolta, Inc. (JP) | 2016-09-06 | — | — | US | disclosed |
| US-9260658-B2 | Organic electroluminescence element, lighting device and display device | Konica Minolta, Inc. (JP) | 2016-02-16 | — | — | US | disclosed |
| US-20150053949-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | Konica Minolta, Inc. (JP) | 2015-02-26 | — | — | US | disclosed |
| US-20140339529-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | Konica Minolta, Inc. (JP) | 2014-11-20 | — | — | US | disclosed |
| US-20140296476-A1 | PRODRUGS AND DRUG-MACROMOLECULE CONJUGATES HAVING CONTROLLED DRUG RELEASE RATES | PROLYNX LLC | 2014-10-02 | — | — | US | disclosed |
| US-20140191227-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT | Konica Minolta, Inc. (JP) | 2014-07-10 | — | — | US | disclosed |
| US-20130049576-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, LIGHTING DEVICE AND DISPLAY DEVICE | KONICA MINOLTA HOLDINGS, INC. (JP) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160315273-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, LIGHTING DEVICE, AND DISPLAY DEVICE | LAGE3, ELOVL1, ELP1 | SMN1; SMN2 656/4885ALDH1A1 768/4885HPGD 3774/4885 |
| US-20140296476-A1 | PRODRUGS AND DRUG-MACROMOLECULE CONJUGATES HAVING CONTROLLED DRUG RELEASE RATES | ABCB1, ABCB11, DNPEP | SMN1; SMN2 1727/4885ALDH1A1 701/4885HPGD 810/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.